Compounds > tripelennamine
Page last updated: 2024-11-05

tripelennamine and Brucellosis

tripelennamine has been researched along with Brucellosis in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FARID, Z1
OMAR, MS1
MIALE, A1
PRASAD, AS1

Other Studies

1 other study available for tripelennamine and Brucellosis

ArticleYear
Treatment of undulant fever.
    Lancet (London, England), 1963, Feb-09, Volume: 1, Issue:7276

    Topics: Brucellosis; Drug Hypersensitivity; Novobiocin; Streptomycin; Tripelennamine

1963